7-141972854-A-T
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_176817.5(TAS2R38):c.836T>A(p.Val279Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000242 in 1,613,756 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_176817.5 missense
Scores
Clinical Significance
Conservation
Publications
- Tourette syndromeInheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000593 AC: 9AN: 151754Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000637 AC: 16AN: 251028 AF XY: 0.0000590 show subpopulations
GnomAD4 exome AF: 0.0000205 AC: 30AN: 1461884Hom.: 1 Cov.: 70 AF XY: 0.0000138 AC XY: 10AN XY: 727244 show subpopulations
GnomAD4 genome AF: 0.0000593 AC: 9AN: 151872Hom.: 0 Cov.: 31 AF XY: 0.0000808 AC XY: 6AN XY: 74212 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.836T>A (p.V279E) alteration is located in exon 1 (coding exon 1) of the TAS2R38 gene. This alteration results from a T to A substitution at nucleotide position 836, causing the valine (V) at amino acid position 279 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at